Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs has informed BSE that its Board of Directors will meet on Friday, November 14, 2025, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 (Q2 and H1 FY26), along with any other business items. The filing is made under SEBI Listing Regulations and is a standard regulatory disclosure. The company has also reiterated that the trading window for dealing in its securities remains closed for designated persons and their immediate relatives until 48 hours after the results are declared.
This is a routine procedural announcement with no direct impact on the stock. Investors should watch for the actual Q2/H1 FY26 results on or after November 14, 2025, which will provide the next meaningful update on the company's financial performance.